Clinical Trials Browser

Genetic Diseases, Inborn × Fulvestrant × 1 year × Clear all

NCT05392608 2026-05-22

SEQUEL-Breast

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn